In light of widely varying LTM treatment responses and the important role of polymorphism in patients with asthma, we systematically reviewed the pharmacogenetic literature on LTM and performed a meta-analysis on LTC4S-444A/C gene polymorphism. This evidence concerns the gene LTC4S and asthma.